Metraipolis › archive › dc_cced0a8971ae
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2 — Europe PMC PMID:40934429
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40934429
- DOI
- 10.1172/jci192052
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T07:21:11.376Z
- SHA-256 of the archived text
2ee3dc2162427c53aed2ea2f8759ff71afaf949efe4855faaf600dd9d33ec27e- Stable URL of this page
https://metraipolis.com/documento/dc_cced0a8971ae
How to cite
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2 — Europe PMC PMID:40934429 — Europe PMC (en), https://europepmc.org/article/MED/40934429 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cced0a8971ae (Metraipolis archive dc_cced0a8971ae, sha256 2ee3dc2162427c53aed2ea2f8759ff71afaf949efe4855faaf600dd9d33ec27e)
BibTeX
@misc{dccced0a8971ae,
title = {Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2 — Europe PMC PMID:40934429},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40934429},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cced0a8971ae; sha256 2ee3dc2162427c53aed2ea2f8759ff71afaf949efe4855faaf600dd9d33ec27e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40934429. Agents can read the archived copy with the MCP tool read_document.